Campaigning (terms considered too vague by the International Bureau - Rule 13 (2) (b) of the Common Regulations); promotional and public awareness campaigns (terms considered too vague by the International Bureau - Rule 13 (2) (b) of the Common Regulations); collection of membership subscriptions for charities; advisory, consultancy and information services (terms considered too vague by the International Bureau - Rule 13 (2) (b) of the Common Regulations)

Charitable fundraising; arranging charitable collections; management and monitoring of charitable funds and payment of funds to charity; financial grant making (terms considered too vague by the International Bureau - Rule 13 (2) (b) of the Common Regulations); benevolent fund services; raising of financial sponsorship; collection of membership fees; provision of financial advice, information and support; advisory, consultancy and information services (terms considered too vague by the International Bureau - Rule 13 (2) (b) of the Common Regulations)

Educational and training services; organising of conferences, seminars, courses, workshops and other events (terms considered too vague by the International Bureau - Rule 13 (2) (b) of the Common Regulations); production of audio and/or video recordings; publishing including online publishing; provision of non-downloadable electronic publications; advisory, consultancy and information services (terms considered too vague by the International Bureau - Rule 13 (2) (b) of the Common Regulations)

Research, including in the field of rare diseases, eye diseases and inherited retinal dystrophies; advisory, consultancy and information services in relation to the aforesaid

Healthcare and medical services, including in relation to the treatment of rare diseases, eye diseases and inherited retinal dystrophies (terms considered too vague by the International Bureau - Rule 13 (2) (b) of the Common Regulations); rehabilitation services in relation to vision impairment and blindness; advisory, consultancy and information services, including in relation to health, healthcare, rare diseases, eye diseases and inherited retinal dystrophies (terms considered too vague by the International Bureau - Rule 13 (2) (b) of the Common Regulations)